Hepatitis C virus (HCV) infection is remarkably efficient in establishing viral persistence,
leading to the development of liver cirrhosis and hepatocellular carcinoma (HCC). Direct …

Immune responses against hepatitis C virus (HCV) play a crucial role in the pathogenesis of
chronic hepatitis C. HCV infection often persists and leads to chronic hepatitis and …

Hepatitis C virus (HCV) infection is one of the major causes of chronic liver disease
worldwide. The critical role of innate as well as adaptive immunity has been reported in HCV …

The hepatitis C virus (HCV) is a major cause of chronic liver disease globally. A chronic
infection can result in liver fibrosis, liver cirrhosis, hepatocellular carcinoma and liver failure …

Hepatitis C virus (HCV) is a highly mutable, hepatotropic RNA virus that causes acute and
chronic hepatitis, affecting over 3% of world population [1–8]. HCV infection frequently …

Chronic hepatitis C (CHC) is a major cause of hepatocellular carcinoma (HCC) worldwide.
While directly acting antiviral (DAA) drugs are now able to cure virtually all hepatitis C virus …

Over recent years, it has become increasingly accepted that virus-specific CD4+ and CD8+
T cell responses play a major role in outcome and pathogenesis of hepatitis C virus (HCV) …

Direct-acting antiviral agents (DAAs) that allow for rapid clearance of hepatitis C virus (HCV)
may evoke immunological changes. Some cases of rapid de novo hepatocellular carcinoma …

HCV (hepatitis C virus) has a high propensity to persist and to cause chronic hepatitis C,
eventually leading to cirrhosis. Since HCV itself is not cytopathic, liver damage in chronic …

Hepatitis C virus (HCV) often causes persistent infection, and is an important factor in the
etiology of fibrosis, cirrhosis, and hepatocellular carcinoma (HCC). There are no preventive …